Lv1
78 积分 2022-05-24 加入
Translational Medicine in Hormone Receptor–Positive Breast Cancer: The Journey of Inavolisib (Itovebi™) from Mutation to Clinical Success
1个月前
已关闭
Pan-cancer spatial atlas of tertiary lymphoid structures
1个月前
已完结
A machine learning model integrating circulating Temra cell transcriptional profiles to predict immunotherapy efficacy
4个月前
已完结
Pan-cancer tumor classification by a holistic tumor microenvironment atlas
4个月前
已完结
Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant immunochemotherapy in gastric cancer
5个月前
已完结
Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant immunochemotherapy in gastric cancer
5个月前
已完结
Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
5个月前
已完结
Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
5个月前
已完结
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
6个月前
已完结
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
6个月前
已完结
皖公网安备34019202002308
